EP2704798
Samsetning fyrir and-ALFA4 BETA7 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.5.2012EP published:
12.7.2017EP application number:
12721093.8
EP translation filed:
10.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
1.5.2032Expiry date:
1.5.2027Next due date:
31.5.2027
Title:
FORMULATION FOR ANTI- ALPHA4BETA7 ANTIBODY
Timeline
Today
2.5.2012EP application
12.7.2017EP Publication
10.10.2017Translation submitted
15.11.2017Registration published
1.5.2027Expires
Owner
Name:
Millennium Pharmaceuticals, Inc.Address:
40 Landsdowne Street, 02139, Cambridge, MA, US
Inventor
Name:
DILUZIO, WillowAddress:
WestfordMassachusetts, US
Name:
TRUONG, Nobel T.Address:
MilfordMassachusetts, US
Name:
VARGA, Csanad M.Address:
Newton, MA, US
Name:
PALANIAPPAN, VaithianathanAddress:
AndoverMassachusetts, US
Name:
BROWN, JasonAddress:
BurlingtonMassachusetts, US
Name:
FOX, Irving H.Address:
WellesleyMassachusetts, US
Name:
SCHOLZ, CatherineAddress:
WoburnMassachusetts, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161481533 PDate:
2.5.2011Country:
US
Number:
201161550545 PDate:
24.10.2011Country:
US
Number:
201261585859 PDate:
12.1.2012Country:
US
Classification
Categories:
A61P 1/00, A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.4.2018
Expires: 1.5.2019
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 23.4.2019
Expires: 1.5.2020
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.4.2020
Expires: 1.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 20.4.2021
Expires: 1.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 19.4.2022
Expires: 1.5.2023
Payer: Patice ehf.
Number: 12
Paid: 22.4.2023
Expires: 1.5.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 19.4.2024
Expires: 1.5.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.5.2025
Expires: 1.5.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 11.5.2026
Expires: 1.5.2027
Payer: Árnason Faktor ehf.